Anzeige
Mehr »
Login
Montag, 05.06.2023 Börsentäglich über 12.000 News von 686 internationalen Medien
Vollgas-Montag! NuGen Medical: Kurs hebt ab!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 865311 | ISIN: US6778641000 | Ticker-Symbol: O4D
Frankfurt
05.06.23
08:00 Uhr
36,800 Euro
+1,600
+4,55 %
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
OIL-DRI CORPORATION OF AMERICA Chart 1 Jahr
5-Tage-Chart
OIL-DRI CORPORATION OF AMERICA 5-Tage-Chart
RealtimeGeldBriefZeit
35,20036,00022:00
GlobeNewswire (Europe)
856 Leser
Artikel bewerten:
(2)

Oil-Dri Corporation Of America: Amlan® International Welcomes New Director of Sales for Latin America

Dr. Robin Jarquin appointed to drive sales and expand operations in the LATAM market

CHICAGO, March 21, 2023 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America and a global leader in natural, mineral-based feed additives that optimize the intestinal health of poultry and livestock, announces the appointment of Dr. Robin Jarquin as its Director of Sales, LATAM. In this role, Dr. Jarquin will work to advance Amlan's development strategies and present mineral-based solutions for customers in Mexico, Central America, South America and the Caribbean. Dr. Jarquin will also be responsible for recruiting and hiring new industry partnerships and talent to expand operations in the LATAM market.

Amlan is proud to be expanding operations in LATAM, a region that produced 28 million tons of broiler meat in 2021 alone. With its recent registration of innovative products like anticoccidial alternative Phylox® in Mexico and Chile, Amlan continues to deliver on its mission to provide high quality mineral-based feed additives to producers around the world.

"Dr. Jarquin's deep understanding of the poultry industry and vast experience in sales and technical support will propel Amlan's efforts in supporting LATAM's broiler meat production which accounts for 22 percent of the world's production," said Heath Wessels, Vice President of Sales, The Americas. "With Dr. Jarquin's expertise, we are eager to reinforce our unique product benefits with stakeholders and decision makers to drive strategic opportunities for market share expansion in the region."

Over the last five years, pork production in Latin America has grown over 20 percent and is responsible for nearly 40 percent of all the pork meat produced in the Americas.

"In addition to poultry, swine is a strong area of growth for Amlan in LATAM with our products Calibrin®-Z and NeoPrime® which are available in select international markets," said Dr. Wade Robey, Vice President of Agriculture, Oil-Dri, and President of Amlan International. "Dr. Jarquin will also play a critical role in leading product strategies and development efforts for swine in LATAM as pork meat production continues to rise in the region."

Dr. Jarquin spent over 17 years at a major poultry production company, most recently serving as Vice President of North American Sales and Tech Services. In this role, Dr. Jarquin was responsible for establishing new business partnerships and managing all commercial and technical service activities for the North American region. Previously, Dr. Jarquin held positions as a microbiologist, Director of World Technical Services, and Sales Manager (CAMEX region).

About Amlan® International
Amlan International is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Oil-Dri leverages over 80 years of expertise in mineral science to selectively mine and process its unique mineral for consumer and business-to-business markets. Oil-Dri Corporation of America doing business as "Amlan International" is a publicly traded stock on the New York Stock Exchange.

Media Contact
Reagan Culbertson
VP, Strategic Marketing
Press@amlan.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cdf0b4fe-e21e-449b-a43f-89481e298581


Das ultimative Rendite-Paket für unruhige Zeiten
Big Pharma Boom! Stabile Erträge, günstige Bewertung. Chart-Profi Stefan Klotter hat für Sie exklusiv fünf Blue Chips aus der Pharma-Branche gefunden. Jetzt kostenlos herunterladen!
Hier klicken
© 2023 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.